News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - IPO, Updates (World)
Affimed Therapeutics AG (AFMD) Announces Closing Of Initial Public Offering 9/18/2014
Auris Medical AG (EARS) Announces Exercise Of IPO Over-Allotment Option 8/20/2014
Israeli Biotech Foamix Files For A $75 Million IPO 8/14/2014
Multiple Sclerosis Biotech Forward Pharma Files For $200 Million IPO 8/12/2014
Innocoll AG Announces Pricing Of Initial Public Offering 7/25/2014
Orthocell Raises $8 Million In Oversubscribed IPO 7/22/2014
Luye Pharma Group Ltd. Completes Successful IPO In Hong Kong 7/14/2014
Luye Pharma Group Ltd. Prices Hong Kong IPO At Top Of Range 7/7/2014
GW Pharmaceuticals Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Totaling Approximately $169.8 Million On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional Adss 6/26/2014
GlaxoSmithKline (GSK) Spin-Off Convergence Pharmaceuticals Gears Up For Possible Listing 6/17/2014
Dutch Biotech arGEN-X Plans To Go Public In Brussels 6/10/2014
Orthocell IPO Opens 6/5/2014
MediWound (MDWD) Prices IPO At $14 Share 3/20/2014
Galmed Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/18/2014
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014
Galmed Pharmaceuticals Debuts Upsized IPO, Raises $38 Million 3/13/2014
NeuroVive Pharmaceutical AB: Neurovive Starts Collaboration To Evaluate IPO Of Subsidiary In Taiwan 3/10/2014
Durham's SCYNEXIS, Inc. Files For $55 Million IPO 3/3/2014
Beijing Genomics Institute (BGI) Rumored To Stage $400 Million IPO In Late 2014 2/24/2014
Luye Pharma Group Ltd. To Conduct $750 Million Hong Kong IPO 2/10/2014
Circassia Limited Seeks $285 Million In One Of Europe's Biggest Biotech IPOs 2/6/2014
uniQure Announces Pricing Of Initial Public Offering 2/5/2014
Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO 2/4/2014
Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO 1/27/2014
Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO 1/27/2014
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014
Jiangsu ASK Pharma Postpones ChiNext IPO 1/13/2014
Seattle Biotech Acucela Inc. Seeks $125 Million IPO in Japan to Develop Eye Drugs 12/18/2013
Consun Pharma Schedules Hong Kong IPO 12/13/2013
Innate Immunotherapeutics Launches IPO To Raise Up To A$12 Million 11/27/2013
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013
Enzymotec Announces Pricing of Its Initial Public Offering 9/27/2013
Prosensa Holding N.V. Announces Closing of Initial Public Offering 7/8/2013
ProSensa B.V. Raises $78 Million in IPO 6/28/2013
CSRC Terminates IPO Applications of 15 China Life Science Companies 6/6/2013
Kamada Ltd. (KMDA.TA) Announces Pricing of Initial Public Offering 6/5/2013
Cancer Drug Spinoff of Australian Company, Audeo Oncology Inc. Preps $49 Million IPO 12/10/2012
BioIndustry Association Release: Latest French Biotech IPO Demonstrates the Potential of Citizens' Innovation Funds 10/25/2012
Fosun Pharma's Hong Kong IPO Set to Raise $600 Million 10/5/2012
China National Biotech Group Approved for $1.6 Billion Hong Kong IPO 9/6/2012
The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs 8/21/2012
Tigermed Completes $80 Million IPO on the ChiNext Exchange 8/20/2012
Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen 8/15/2012
Cathay Industrial Biotech Withdraws $90 Million IPO 6/13/2012
China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO 5/18/2012
Fosun Pharma Given OK for Hong Kong IPO 4/12/2012
Beijing Leadman Biochemistry Completes ChiNext IPO 2/16/2012
Chinese Drugmaker Guizhentang Pharmaceuticals' IPO Protested Over Bear Bile 2/13/2012
Xizang Haisco Pharma Completes $127 Million IPO 1/17/2012
China National Biotech Group's Hong Kong IPO to Raise Up to $2 Billion 11/9/2011
Shijiazhuang Yiling Pharmaceutical Climbs in Post-IPO Trading 7/28/2011
U.S. HIV Drug Firm Koronis Pharmaceuticals, Inc. Looks to London Listing 3/14/2011
CRO ShangPharma Plans $90 Million IPO on the NYSE 10/5/2010
Yunnan Walvax Biotech to IPO on ChiNext Exchange 9/14/2010
China Pharma IPOs Raise $5.4 Billion in 12 Months 7/26/2010



//-->